Evidence map›Paper›PMID 40871068›Full record

ArticlePharmaceutics2025

Enhancing Chemical Stability and Bioavailability of Aneratrigine Capsules via Dry Granulation: Addressing Stability Challenges in Sodium Bicarbonate-Containing Formulations for Clinical Development.

Kwan-Ik Cha, Ga-Eon Kim, Ji-Hyung Seol, Dong-Woo Kim, Seungbeom Lee

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kwan-Ik ChaNew Drug Formulation Team, iN Therapeutics Co., Ltd., Yongin-si 17028, Republic of Korea.
Ga-Eon KimNew Drug Formulation Team, iN Therapeutics Co., Ltd., Yongin-si 17028, Republic of Korea.
Ji-Hyung SeolNew Drug Formulation Team, iN Therapeutics Co., Ltd., Yongin-si 17028, Republic of Korea.
Dong-Woo KimNonclinical Research Center, iN Therapeutics Co., Ltd., Yongin-si 17028, Republic of Korea.ORCID 0009-0007-0351-3740
Seungbeom LeeMedicinal Chemistry and New Drug Formulation Center, iN Therapeutics Co., Ltd., Yongin-si 17028, Republic of Korea.ORCID 0000-0003-3852-3723

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alkalizing agentaneratriginedesign of experimentsdry granulationNav1.7 inhibitor

Identifiers

PMID40871068
PMCPMC12388960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.